Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
How United UMC prepares for market disruptions Q1 2026 EPS Tops Views Is Halozyme Therapeutics HALO stock reacting to risk factors 006 20260420 Is Gemini GEMI stock under speculative pressure Creeps Higher 20260422 White WPAC Stock Is It a Good Opportunity WPAC Latest Quarter Earnings Premerger White posts no operating revenue or EPS HKPD Cellyan posts 217 percent Q2 2025 revenue growth shares drop 658 percent amid negative earnings OZ Belpointe management prioritizes targeted real estate acquisitions to boost longterm shareholder value over the full fiscal year CURR Currenc delivers far better than expected Q3 2025 earnings shares rise 627 percent in todays trading What Thermon THR accounting reveals about the business Thermon posts 123 EPS beat vs analyst estimates The growth trajectory Reinsurance RGA is on and where it leads 109 20260505 Nuveen SP SPXX Slips 100 Testing 1692 Support 20260515 Viatris VTRS Stock Today Rallies 055 Resistance at 1740 20260518 Ferrari RACE Reports Strong Q1 2026 Revenue NA EPS Beats Stocks Edge Lower as Oil Gains on Iran Tensions Markets Await Nvidia Earnings and Fed Minutes XP Inc Q1 2026 Earnings Call Highlights Strategic Focus and Market Position Floor FND Q1 2026 Results Miss Estimates EPS 037 vs 042 PNRG Q4 2025 Earnings Strong EPS Performance Amidst Market Uncertainty McKinsey Report Highlights AI and Autonomous Agents as Transformative Force for ERP Systems MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Robust Demand SMTC Q1 2026 Earnings EPS Surges 106 Above Estimates Yet Stock Slides 44 IBOC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Rapid7 RPD Q1 2026 Earnings EPS Surges Past Estimates as Cybersecurity Demand Remains Strong XCUR Q2 2022 Earnings EPS Miss Widens as PreRevenue Biotech Shares Edge Higher Arcturus Therapeutics ARCT Surges 62 as Buyers Defend Key Support Bon Natural Life Limited BON Holds Steady at 127 Amid Low Volatility Toll Brothers TOL Advances 26 Homebuilder Shares Test Key Resistance Zone SMXWW Holds at 004 as Trading Remains RangeBound